Regeneron Pharmaceuticals, Inc.
Close on Nov 20, 2026Market cap $95.24BP/E 20.3Yield –
Regeneron Pharmaceuticals Libtayo by Quarter
Libtayo — U.S. Net Product Sales Recorded by Regeneron ($M) ($M)
Regeneron Pharmaceuticals Libtayo: $396M in Q3 2026, up 80.6% from a year earlier. That is the highest of the 35 quarters on record here.
Where the Q3 2026 figure comes from
Source: Form 10-Q (filed 2026-10-30) ↗
Reported in Form 10-Q / 10-K Note — Net Product Sales (XBRL).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up libtayo
Cite this data
StockData. (2026). Regeneron Pharmaceuticals Libtayo ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/rev-libtayo-us
See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?